As the legal landscape for reproductive rights in the US remains in flux, Democrats in the Senate are calling on the Biden administration to require health insurers to fully cover the recently approved over-the-counter birth control pill.
The FDA this past July approved Perrigo’s Opill as the first OTC birth control option in the US, which is expected to hit shelves next year. But the question of whether and how insurers will cover it remains outstanding.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.